Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODERN: Maraviroc vs TDF/FTC in HIV-1
NCT01345630Phase 3Terminated
- Sponsor
- ViiV Healthcare
- Start
- Sep 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 19
01
Overview
A Phase 3 trial of maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Sep 2011; status: terminated.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01345630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01345630.